Peyer James 13D and 13G filings for Sensei Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 5:16 pm Purchase |
2022-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Peyer James | 5,235,956 17.000% |
5,235,956 (New Position) |
Filing |
| 2021-02-16 10:59 am Purchase |
2021-02-03 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Peyer James | 4,690,153 15.300% |
4,690,153 (New Position) |
Filing |